As so far, several ‘classical’ protein tyrosine phosphatases are attractive therapeutic targets, including PTP1B for obesity and type II diabetes; as well as SHP2 for cancer and Lyp for rheumatoid arthritis [3]. The gene discussed is PTPN1; the disease is type 2 diabetes mellitus.